Pharming Group NV - ADRPHAR
13F holders, Q3 2024 (September 30)4holders
1new positions
2sold out
$8.25avg. 13F price*
At the end of Q3 2024, 4 institutions reported holding Pharming Group NV - ADR (PHAR) in their 13F filings, unchanged from Q2 2024. 1 opened new positions and 2 sold out. The largest holders were Silverberg Bernstein Capital Management LLC ($339K), Morgan Stanley ($27K) and BlackRock, Inc. ($3K).
- Company
- Pharming Group NV - ADR
- CUSIP
- 71716E105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $91 |
| Exits | 2 | $11K |
All 13F filers, Q2 2024 → Q3 2024: 18,186 shares bought and 1,357 shares sold, net +16,829 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Silverberg Bernstein Capital Management LLC | 0.31% | Add +75.4% | 41,110 | $339K |
| Morgan Stanley | 0.00% | Add +17.9% | 3,300 | $27K |
| BlackRock, Inc. | 0.00% | — | 326 | $3K |
| Farther Finance Advisors, LLC | 0.00% | New | 11 | $91 |
"% of holder's portfolio" is PHAR's weight in each manager's 13F, not the share of Pharming Group NV - ADR the manager owns.